Department of Neurology, University Hospital of Dijon, and Centre of Epidemiology of the Populations, Burgundy University, 3 rue du Faubourg Raines, 21000 Dijon, France.
Brain. 2010 Jul;133(Pt 7):1889-99. doi: 10.1093/brain/awq134. Epub 2010 Jun 15.
France is located in an area with a medium to high prevalence of multiple sclerosis, where its epidemiology is not well known. We estimated the national and regional prevalence of multiple sclerosis in France on 31 October 2004 and the incidence between 31 October 2003 and 31 October 2004 based on data from the main French health insurance system: the Caisse Nationale d'Assurance Maladie des Travailleurs Salariés. The Caisse Nationale d'Assurance Maladie des Travailleurs Salariés insures 87% of the French population. We analysed geographic variations in the prevalence and incidence of multiple sclerosis in France using the Bayesian approach. On the 31 October 2004, 49 417 people were registered with multiple sclerosis out of the 52 359 912 insured with the Caisse Nationale d'Assurance Maladie des Travailleurs Salariés. Among these, 4497 were new multiple sclerosis cases declared between 31 October 2003 and 31 October 2004. After standardization for age, total multiple sclerosis prevalence in France was 94.7 per 100,000 (94.3-95.1); 130.5 (129.8-131.2) in females and 54.8 (54.4-55.3) in males. The national incidence of multiple sclerosis between 31 October 2003 and 31 October 2004 was 7.5 per 100,000 (7.3-7.6); 10.4 (10.2-10.6) in females and 4.2 (4.0-4.3) in males. The prevalence and incidence of multiple sclerosis were higher in North-Eastern France, but there was no obvious North-South gradient. This study is the first performed among a representative population of France (87%) using the same method throughout. The Bayesian approach, which takes into account spatial heterogeneity among geographical units and spatial autocorrelation, did not confirm the existence of a prevalence gradient but only a higher prevalence of multiple sclerosis in North-Eastern France and a lower prevalence of multiple sclerosis in the Paris area and on the Mediterranean coast.
法国位于多发性硬化症中高度流行地区,其流行病学特征尚未完全明晰。我们根据法国主要医疗保险系统(即全国职工健康保险联盟)的数据,于 2004 年 10 月 31 日估计了法国多发性硬化症的全国和地区患病率,以及 2003 年 10 月 31 日至 2004 年 10 月 31 日期间的发病率。全国职工健康保险联盟为 87%的法国人口提供医疗保险。我们使用贝叶斯方法分析了法国多发性硬化症的流行率和发病率的地域变化。2004 年 10 月 31 日,全国职工健康保险联盟的 52359912 名被保险人中,有 49417 人被确诊患有多发性硬化症。在这些患者中,有 4497 例是在 2003 年 10 月 31 日至 2004 年 10 月 31 日期间新确诊的多发性硬化症病例。经年龄标准化后,法国多发性硬化症的总流行率为 94.7/10 万(94.3-95.1);女性为 130.5(129.8-131.2),男性为 54.8(54.4-55.3)。2003 年 10 月 31 日至 2004 年 10 月 31 日期间,法国多发性硬化症的全国发病率为 7.5/10 万(7.3-7.6);女性为 10.4(10.2-10.6),男性为 4.2(4.0-4.3)。法国东北部的多发性硬化症患病率和发病率较高,但没有明显的南北梯度。这是首次在代表法国 87%人口的代表性人群中使用相同方法进行的研究。贝叶斯方法考虑了地理单位之间的空间异质性和空间自相关,并未证实流行率存在梯度,但仅证实了东北部法国多发性硬化症的流行率较高,巴黎地区和地中海沿岸的多发性硬化症的流行率较低。